PMID- 19093256 OWN - NLM STAT- MEDLINE DCOM- 20090127 LR - 20081218 IS - 1532-4192 (Electronic) IS - 0735-7907 (Linking) VI - 26 IP - 10 DP - 2008 Dec TI - Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene. PG - 984-9 LID - 10.1080/07357900802072897 [doi] AB - The purpose of this study was to explore the inhibiting role of MMP-9 gene silence in the invasive ability and growth of laryngeal squamous cell carcinoma (LSCC) by lentivirus mediated RNA interference. MMP-9-RNAi-lentivirus and the control lentivirus (GFP-lentivirus) were transfected into Hep-2 cells. Gelatin zymography showed the proteins expression of MMP-9 were knockdown in the MMP-9 siRNA transfected Hep-2 cells. The invasive activity and viability of MMP-9 siRNA treated Hep-2 cells were decreased than the control cells measured with modified Boyden chamber assay and MTT assay. In animal experiment, 20 nude mice bearing Hep-2 cell tumor were randomly separated into the experimental and the control groups. The former were intratumorally injected with MMP-9-RNAi-lentivirus, and the later were injected with equivalent dose of GFP-lentivirus. Results showed the average weight and volume of tumor in MMP-9-RNAi-lentivirus treated group were significantly lower than those in the control group (P < .01). The protein expressions of MMP-9 were downregulated in tumors of MMP-9-RNAi-lentivirus treatment. The PCNA index was obviously lower in the tumors of treated group than that in the control group (P < .01). These results suggest that MMP-9 gene silence by lentivirus mediated RNA interference can inhibit invasion and growth of LSCC. FAU - Sun, Yanan AU - Sun Y AD - The Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, PR China. FAU - Liu, Ming AU - Liu M FAU - Yang, Baofeng AU - Yang B FAU - Lu, Jianguang AU - Lu J FAU - Li, Baoxin AU - Li B LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Cancer Invest JT - Cancer investigation JID - 8307154 RN - 0 (RNA, Catalytic) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Carcinoma, Squamous Cell/enzymology/genetics/*pathology MH - Cell Division MH - Cell Line, Tumor MH - Gene Expression Regulation, Enzymologic MH - Gene Expression Regulation, Neoplastic MH - Gene Silencing MH - Genetic Vectors MH - Humans MH - Laryngeal Neoplasms/*enzymology/genetics/*pathology MH - Lentivirus/*genetics MH - Matrix Metalloproteinase 9/*genetics MH - Mice MH - Mice, Nude MH - Neoplasm Invasiveness MH - *RNA Interference MH - RNA, Catalytic/*genetics MH - Transfection EDAT- 2008/12/19 09:00 MHDA- 2009/01/28 09:00 CRDT- 2008/12/19 09:00 PHST- 2008/12/19 09:00 [entrez] PHST- 2008/12/19 09:00 [pubmed] PHST- 2009/01/28 09:00 [medline] AID - 906934709 [pii] AID - 10.1080/07357900802072897 [doi] PST - ppublish SO - Cancer Invest. 2008 Dec;26(10):984-9. doi: 10.1080/07357900802072897.